Loading...
PMV Pharmaceuticals Inc (PMVP) is not a good buy for a beginner, long-term investor at this time. The stock shows bearish technical indicators, lacks strong positive catalysts, and has weak financial performance. Additionally, no significant trading signals or influential figure activity supports a buy decision.
The technical indicators for PMVP are bearish. The MACD is slightly positive but contracting, RSI is neutral at 45.122, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point of 1.093, with resistance at 1.154 and support at 1.032. Historical trends suggest a likelihood of further decline in the next day (-0.05%), week (-2.57%), and month (-5.83%).

Hedge funds are significantly increasing their positions in the stock, with a 2450.33% increase in buying activity over the last quarter.
Insiders are neutral with no significant trading activity. The company has no recent news or event-driven catalysts. Historical stock trends indicate a high probability of further price decline in the short to medium term.
The financial performance of PMVP in Q3 2025 shows weak fundamentals. Revenue remains at $0 with no growth YoY. Net income is negative at -$21,059,000, though it improved by 9.53% YoY. EPS is negative at -0.4, with a slight improvement of 8.11% YoY. Gross margin is 0, indicating no profitability.
No recent analyst ratings or price target changes are available for PMVP.